Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy
Gastrointestinal tumors, including pancreatic and colorectal cancers, represent one of the greatest public health issues worldwide, leading to a million global deaths. Recent research demonstrated that the human heavy chain ferritin (HFt) can encapsulate different types of drugs in its cavity and ca...
Main Authors: | Elisabetta Falvo, Alessandro Arcovito, Giamaica Conti, Giuseppe Cipolla, Martina Pitea, Veronica Morea, Verena Damiani, Gianluca Sala, Giulio Fracasso, Pierpaolo Ceci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/10/992 |
Similar Items
-
Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model
by: Giamaica Conti, et al.
Published: (2021-11-01) -
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers
by: Giulio Fracasso, et al.
Published: (2023-10-01) -
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors
by: Elisabetta Falvo, et al.
Published: (2021-02-01) -
Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition
by: Masahiro Nishida, et al.
Published: (2022-09-01) -
Antiparasitic effect of synthetic aromathecins on Leishmania infantum
by: Rosa M. Reguera, et al.
Published: (2019-11-01)